Categories: FinancialNews

Fullpower®-AI Announces the Issuance of Three New U.S. Patents Further Covering Smart Beds, Sleeptracker®-AI, and the Fullpower®-AI PaaS Platform

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SANTA CRUZ, Calif., July 14, 2022 /PRNewswire/ — Fullpower®-AI, the leading IoT biosensing and sleep technology company, today announced that the United States Patent and Trademark Office (USPTO) had issued three new U.S. Patents directed to methods related to the Fullpower®-AI platform.

“We are extremely pleased, as inventors and pioneers, with the continued development of the Fullpower®-AI patent portfolio. These new issuances, some with early priorities, continue to expand the breadth and depth of our Sleep and Biosensing intellectual property portfolio, covering methods important to Smart beds, Sleep, Snoring, Apnea, Wearable, IoT, Machine Learning, and other industries. The issuance of these patents is another step in the development of our robust patent portfolio,” said Philippe Kahn, Chief Executive Officer of Fullpower®-AI.

Patent Title

Priority Date

Patent Number

Issue Date

Multi-Zone Adjustable Bed with Smart Adjustment Mechanism

3/26/18

11253079

2/22/22

Sleep Detection and Analysis System

10/15/18

11382534

7/12/22

Sleep Quality Optimization Using a Controlled Sleep Surface

9/19/11

11344460

5/31/22

About Fullpower Technologies, Inc.

Fullpower® Technologies delivers a complete B2B IoT platform for AI-powered algorithms, remote contactless biosensing, end-to-end engineering services, and software customization in life sciences, health, and biotechnology. Fullpower’s platform is vetted and deployed as an IoT PaaS, backed by a patent portfolio of 135+ patents.

Fullpower’s key areas of expertise include:

  • Clinically validated sleep technology: Sleeptracker-AI®
  • Worldwide vetted IoT edge-cloud platform deployments
  • AI-powered IoT biosensing
  • Remote non-invasive vital signs monitoring
  • The development of new AI-powered technologies in life sciences and biotechnology fields

Fullpower’s B2B PaaS customers are in medical solutions, remote biosensing, sleep, bedding solutions, wearable, and wellness services.

For more information, visit www.fullpower.com or contact BusDev@fullpower.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/fullpower-ai-announces-the-issuance-of-three-new-us-patents-further-covering-smart-beds-sleeptracker-ai-and-the-fullpower-ai-paas-platform-301586769.html

SOURCE Fullpower

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

7 hours ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

7 hours ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

10 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

10 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

10 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

13 hours ago